155 related articles for article (PubMed ID: 2161510)
1. Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. A pilot study.
Lehn P; Quessar A; Devergie A; Esperou-Bourdeau H; Traineau R; Trédaniel J; Benbunan M; Bussel A; Jolivet I; Mazeron MC
Nouv Rev Fr Hematol (1978); 1990; 32(1):17-20. PubMed ID: 2161510
[TBL] [Abstract][Full Text] [Related]
2. Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up.
Zaia JA; Schmidt GM; Chao NJ; Rizk NW; Nademanee AP; Niland JC; Horak DA; Lee J; Gallez-Hawkins G; Kusnierz-Glaz CR
Biol Blood Marrow Transplant; 1995 Dec; 1(2):88-93. PubMed ID: 9118297
[TBL] [Abstract][Full Text] [Related]
3. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy.
Mandanas RA; Saez RA; Selby GB; Confer DL
Am J Hematol; 1996 Feb; 51(2):104-11. PubMed ID: 8579049
[TBL] [Abstract][Full Text] [Related]
5. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.
Ljungman P; De Bock R; Cordonnier C; Einsele H; Engelhard D; Grundy J; Locasciulli A; Reusser P; Ribaud P
Bone Marrow Transplant; 1993 Oct; 12(4):399-403. PubMed ID: 8275040
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir and standard high-dose immunoglobulins for the treatment of cytomegalovirus interstitial pneumonia in a bone marrow recipient.
Iori AP; Gentile G; Petasecca Donati P; Arcese W; Martino P; Mandelli F
Haematologica; 1990; 75(4):394-6. PubMed ID: 2177441
[TBL] [Abstract][Full Text] [Related]
7. CMV pneumonia in allogeneic BMT recipients undergoing early treatment of pre-emptive ganciclovir therapy.
Machado CM; Dulley FL; Boas LS; Castelli JB; Macedo MC; Silva RL; Pallota R; Saboya RS; Pannuti CS
Bone Marrow Transplant; 2000 Aug; 26(4):413-7. PubMed ID: 10982288
[TBL] [Abstract][Full Text] [Related]
8. Rapid detection cytomegalovirus pneumonia in recipients of bone marrow transplant: evaluation and comparison of five survey methods for bronchoalveolar lavage fluid.
Goto H; Yuasa K; Sakamaki H; Nakata K; Komuro I; Iguchi M; Okamura T; Ieki R; Tanikawa S; Akiyama H; Onozawa Y; Mochida Y
Bone Marrow Transplant; 1996 May; 17(5):855-60. PubMed ID: 8733709
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infection presenting as polyarticular arthritis following autologous BMT.
Burns LJ; Gingrich RD
Bone Marrow Transplant; 1993 Jan; 11(1):77-9. PubMed ID: 8381695
[TBL] [Abstract][Full Text] [Related]
10. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic use of ganciclovir for allogeneic bone marrow transplant recipients.
von Bueltzingsloewen A; Bordigoni P; Witz F; Bene MC; Schmitt C; Lacour B; Sommelet D
Bone Marrow Transplant; 1993 Sep; 12(3):197-202. PubMed ID: 8241976
[TBL] [Abstract][Full Text] [Related]
12. Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir.
Bacigalupo A; van Lint MT; Tedone E; Moro F; Sanna MA; Longren M; Trespi G; Frassoni F; Occhini D; Gualandi F
Bone Marrow Transplant; 1994 Jun; 13(6):753-8. PubMed ID: 7920310
[TBL] [Abstract][Full Text] [Related]
13. CMV prophylaxis in allogeneic BMT with ganciclovir and CMV immune globulin.
Patton WN; Carter C; Bienz N; Lamb T; Boughton BJ; Franklin IM
Bone Marrow Transplant; 1991; 7 Suppl 2():44. PubMed ID: 1652330
[No Abstract] [Full Text] [Related]
14. [Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
Gluckman E; McMazeron ; Keable H; Meletis J; Bombail D; Jolivet I; Huart JJ; Nebout T; Cavazzana M; De Castro H
Nouv Rev Fr Hematol (1978); 1987; 29(1):17-21. PubMed ID: 3035485
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.
Ljungman P
Semin Respir Infect; 1995 Dec; 10(4):209-15. PubMed ID: 8668848
[TBL] [Abstract][Full Text] [Related]
16. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
Verdonck LF; de Gast GC; Dekker AW; de Weger RA; Schuurman HJ; Rozenberg-Arska M
Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
[TBL] [Abstract][Full Text] [Related]
18. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
[TBL] [Abstract][Full Text] [Related]
19. [Clinical, diagnostic and physiopathological aspects of cytomegalovirus pneumonia after bone marrow transplantation].
Cordonnier C
Rev Pneumol Clin; 1990; 46(6):244-50. PubMed ID: 1965751
[TBL] [Abstract][Full Text] [Related]
20. Three weeks of ganciclovir for cytomegaloviraemia after allogeneic bone marrow transplantation.
Singhal S; Mehta J; Powles R; Treleaven J; Horton C; Carrington D; Tryhorn Y; Jameson B
Bone Marrow Transplant; 1995 May; 15(5):777-81. PubMed ID: 7670405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
